ClinicalTrials.Veeva

Menu

Performance of Whole Body MRI in Extraplevic Disease Detection in Patients Undergoing Pelvic Exenteration for Gynecological Maligniancies (WHOLE BODY)

I

Institute of Hospitalization and Scientific Care (IRCCS)

Status

Enrolling

Conditions

Gynecologic Cancer

Study type

Observational

Funder types

Other

Identifiers

Details and patient eligibility

About

The aim of this prospective observational diagnostic study is to investigate the diagnostic accuracy od extrapelvic disease detection using Whole-body-MRI (WB-MRI) in patients with gynecologic cancer candidate to the pelvic exenteration.

Enrollment

71 estimated patients

Sex

Female

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Age > 18 years
  • Written Informed Consent
  • All patients with recurrent gynecological cancer that are planned to undergo pelvic exenteration or laterally extended pelvic resection, both with curative and palliative intent
  • Patients considered fit for srugery

Exclusion criteria

  • Controindication to MRI (Claustrophobia, implanted ferromagnetic materials or foreign objects, Known intolerance or controindication to the MRI contrast agent, cardiac pacemaker)
  • Individuals who are not able or willing to tolerate the required prologed stationary supine position during examination (approximately 40-60 minutes)
  • Patient unable to give informed consent

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems